Ivan Plavec
DiscoveRx (United States)(US)
Publications by Year
Research Areas
Virus-based gene therapy research, HIV Research and Treatment, CRISPR and Genetic Engineering, Computational Drug Discovery Methods, CAR-T cell therapy research
Most-Cited Works
- → A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation(2012)143 cited
- → A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor(1993)103 cited
- → RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication(1997)100 cited
- → A Novel Human Amphotropic Packaging Cell Line: High Titer, Complement Resistance, and Improved Safety(1996)90 cited
- → Scaffold Attachment Region-Mediated Enhancement of Retroviral Vector Expression in Primary T Cells(1998)88 cited
- → An integrative biology approach for analysis of drug action in models of human vascular inflammation(2004)87 cited
- → Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis in Complex Human Primary Cell-Based Models(2004)83 cited
- → Construction and Molecular Analysis of Gene Transfer Systems Derived from Bovine Immunodeficiency Virus(2001)83 cited
- → High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS(1997)77 cited
- → Human Beta Interferon Scaffold Attachment Region Inhibits De Novo Methylation and Confers Long-Term, Copy Number-Dependent Expression to a Retroviral Vector(2000)67 cited